Derechos | Equipo Nizkor
RDIF agrees to produce Sputnik V vaccine in Turkey
The Russian Direct Investment Fund (RDIF) has agreed on the production of the Sputnik V coronavirus vaccine in Turkey and has begun the process of technology transfer, a fund representative told TASS.
"RDIF signed an agreement with a leading Turkish manufacturer of pharmaceutical items for the production of Sputnik V vaccine in Turkey and began the process of technology transfer. Interaction with the company is carried out as part of RDIF's activities to promote Sputnik V vaccine to foreign markets," the fund said.
The RDIF representative noted that the potential production volume is millions of vaccine doses per year, and the issue of a possible expansion of production in the future is also being discussed.
"The Sputnik V vaccine will be supplied both to the domestic market in Turkey and to other countries. Turkish partners are showing great interest in the Sputnik V vaccine," the fund said.
[Source: Tass, Moscow, 23Jan21]
DDHH en Espaņa
|This document has been published on 29ene21 by the Equipo Nizkor and Derechos Human Rights. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.|